Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT05248334
Eligibility Criteria:
Inclusion Criteria:
* Voluntary and able to sign an informed consent form
* Age ≥18 years
* Documented diagnosis of diabetes mellitus (type I or type II diabetes) as defined by the American Diabetes Association or World Health Organization criteria and glycosylated hemoglobin ≤10% within 2 months
* Willing and able to complete all planned visits and evaluations
* Complete Panretinal photocoagulation
* Retinal repositioning
* Complete postoperative vitreous hemorrhage clearance for more than 1 week and non-absorption of recurrent vitreous hemorrhage for more than 4 weeks (grade 2 and above)
* Early postoperative period (1 week to 1 month postoperatively) and delayed postoperative period (4 weeks to 12 months postoperatively)
Exclusion Criteria:
* Patients with less than 6 months of follow-up
* Silicone oil filling
* Other retinal causes of vitreous hemorrhage
* Tractive retinal detachment, pre-retinal proliferative membrane
* Iris redness, neovascular glaucoma
* History of glaucoma
* Ocular inflammation
* Any other intraocular surgery (e.g., corneal transplantation, glaucoma filtration, corneal transplantation therapy, etc.)
* Patients with best corrected visual acuity manual or worse, patients with a single eye
* Previous cerebrovascular or thromboembolic events, hypertensive disorders, renal disease, current use of anticoagulants
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05248334
Study Brief:
Protocol Section:
NCT05248334